author-photo

Jonathan C. Oh

University of Texas MD Anderson Cancer Center

10

Papers

819

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Gemogenovatucel-T (Vigil) Immunotherapy as Maintenance in Frontline Stage III/IV Ovarian Cancer (VITAL): A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Trial

2021 Obstetrical & Gynecological Survey
Show All
- Source
- Cite
- Save
Citations (0)
Assessment of Low Dose Vigil® Engineered Autologous Tumor Cell (EATC) Immunotherapy in Patients with Advanced Solid Tumors

2017
Show All
- Source
- Cite
- Save
Citations (1)
Risk factors for young premenopausal women with endometrial cancer

2005 Obstetrics & Gynecology
Show All
- Source
- Cite
- Save
Citations (226)
Combined positron emission tomography and computed tomography for the detection of recurrent ovarian mucinous adenocarcinoma

2005 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (11)
Heterogeneity of stage IIIA endometrial carcinomas: Implications for adjuvant therapy

2005 International Journal of Gynecological Cancer
Show All
- Source
- Cite
- Save
Citations (21)
Increased Plasma Levels of Insulin-Like Growth Factor 2 and Insulin-Like Growth Factor Binding Protein 3 Are Associated with Endometrial Cancer Risk

2004 Cancer Epidemiology, Biomarkers & Prevention
Show All
- Source
- Cite
- Save
Citations (37)
A gelatin matrix-thrombin tissue sealant (FloSeal®) application in the management of groin breakdown after inguinal lymphadenectomy for vulvar cancer

2004 International Journal of Gynecological Cancer
Show All
- Source
- Cite
- Save
Citations (26)
Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases

2004 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (190)
Uterine papillary serous carcinoma (UPSC): A single institution review of 129 cases

2003 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (280)